Adient (NYSE:ADNT), a global leader in automotive seating, announced on Monday, April 27, 2026, the acquisition of a foam production plant in Romulus, Michigan.
RedHill Biopharma (NASDAQ:RDHL) reported its full-year 2025 financial results and operational highlights on Monday, April 27, 2026, marking a year of significant portfolio high-grading and successful litigation.
Veradermics (NYSE:MANE) announced positive topline results on Monday from Part A of its Phase 2/3 clinical trial evaluating VDPHL01, a proprietary extended-release oral minoxidil formulation.
Honeywell (NASDAQ:HON) announced on Monday, April 27, 2026, that its Board of Directors has declared a quarterly dividend of $1.19 per share.
Linde (NASDAQ:LIN) announced on Monday, April 27, 2026, that its Board of Directors has declared a quarterly dividend of $1.60 per share.
Oruka Therapeutics (NASDAQ:ORKA) announced positive interim results from its EVERLAST-A Phase 2a trial on Monday, April 27, 2026.
Noble (NYSE:NE) reported strong financial and operational results for the first quarter of 2026 on Monday, highlighting a sequential increase in both revenue and profitability.
Ligand Pharmaceuticals (NASDAQ:LGND) announced on Monday, April 27, 2026, that it has entered into a definitive agreement to acquire XOMA Royalty for $39 per share in cash.
The Real Brokerage (NASDAQ:REAX) and RE/MAX Holdings (NYSE:RMAX) announced on Monday, April 27, 2026, a definitive agreement for Real to acquire RE/MAX Holdings.
Clearmind Medicine (NASDAQ:CMND) announced on Monday, April 27, 2026, that it is evaluating its lead drug candidate, CMND-100 (MEAI), for a potential FDA Breakthrough Therapy Designation (BTD).
GARANTA JÁ SEU GRAFA EDGE
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas
